Browse by Journal Title

2018

The role of PAR1 autoantibodies in patients with primary epithelial ovarian cancer.
Kreienbring, K., Franz, A., Richter, R., Dragun, D., Heidecke, H., Müller, D., Mentze, M., Dechend, R., Sehouli, J. and Braicu, E.I.
Anticancer Research 38 (6): 3619-3625. June 2018

2011

Hepatic arterial infusion in the treatment of liver metastases with PEG liposomes in combination with degradable starch microspheres (DSM) increases tumor 5-FU concentration. An animal study in CC-531 liver tumor-bearing rats.
Pohlen, U., Reszka, R., Buhr, H.J. and Berger, G.
Anticancer Research 31 (1): 147-152. January 2011

2010

Generation of an antibody against the protein phosphatase 1 inhibitor KEPI and characterization of the epitope.
Daskalow, K., Boisguerin, P., Jandrig, B., Van Landeghem, F.K., Volkmer, R., Micheel, B. and Schenk, J.A.
Anticancer Research 30 (5): 1573-1578. May 2010

2005

Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumors.
Jeschke, U., Bischof, A., Speer, R., Briese, V., Richter, D.U., Bergemann, C., Mylonas, I., Shabani, N., Friese, K. and Karsten, U.
Anticancer Research 25 (3): 1581-1589. 1 January 2005

Expression of the Thomsen-Friedenreich (TF) tumor antigen in human abort placentas.
Richter, D.U., Jeschke, U., Bergemann, C., Makovitzky, J., Luthen, F., Karsten, U. and Briese, V.
Anticancer Research 25 (3 A): 1675-1678. 1 January 2005

2004

Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou, A., Iakovou, K., Gikas, E., Fichtner, I., Fiebig, H.H., Kelland, L.R., Double, J.A., Bibby, M.C. and Hendriks, H.R.
Anticancer Research 24 (2): 907-919. March 2004

Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 liver tumor-bearing rabbits.
Pohlen, U., Reszka, R., Schneider, P., Buhr, H.J. and Berger, G.
Anticancer Research 24 (3): 1699-1704. 1 January 2004

2003

Chemo- and radiation sensitivity of xenografted acute lymphoblastic leukemias-correlation to the expression of multidrug resistance proteins.
Fichtner, I., Paal, K., Borgmann, A., Badiali, L., Wurm, R. and Henze, G.
Anticancer Research 23 (3): 2657-2664. May 2003

2002

Hepatocarcinoma cells constitutively expressing adenoviral E1-genes provide a tumor model for intratumoral replication of E1-deficient adenoviruses.
Cichon, G., Boeckh-Herwig, S., Elezkurtaj, S., Schmidt, H.H., Hofmann, C. and Arnold, W.
Anticancer Research 22 (1A): 197-201. May 2002

2001

Up-regulation of telomerase activity in Herpesvirus saimiri immortalized human T-lymphocytes.
Harnack, U., Lehmann, C., Matthes, E. and Pecher, G.
Anticancer Research 21 : 3969-3972. 1 January 2001

Early macrophage and cytokine response during the growth of immunogenic and non-immunogenic murine tumors.
Kisseleva, E., Becker, M., Lemm, M. and Fichtner, I.
Anticancer Research 21 (5): 3477-3484. 1 January 2001

Mucin gene (MUC1) transfer into human dendritic cells by cationic liposomes and recombinant adenovirus.
Pecher, G., Spahn, G., Schirrmann, T., Kulbe, H., Ziegner, M., Schenk, J.A. and Sandig, V.
Anticancer Research 21 (4A): 2591-2596. 1 January 2001

2000

Binding of tumor antigen mucin (MUC1) derived peptides to the heat shock protein DnaK.
Schreiber, J., Stahn, R., Schenk, J.A., Karsten, U. and Pecher, G.
Anticancer Research 20 (5A): 3093-3098. 1 September 2000

Expression of the Thomsen-Friedenreich (TF) antigen in the human placenta.
Richter, D.U., Jeschke, U., Makovitzky, J., Goletz, S., Karsten, U., Briese, V. and Friese, K.
Anticancer Research 20 : 5129-5133. 1 January 2000

1999

Reverse transformation of human mammary carcinoma cells.
Luebbe, L., Schenk, J.A., Naundorf, H., Karsten, U. and Wunderlich, V.
Anticancer Research 19 (6B): 5119-5125. November 1999

Expression of CD44 isoforms in human breast carcinoma xenografts is not influenced by the treatment of mice with cytostatics or (anti-) hormones.
Dehmel, A., Becker, M., Lemm, M. and Fichtner, I.
Anticancer Research 19 : 1977-1987. 1 May 1999

1998

Differential gene expression in mammary carcinoma cell lines: identification of DRIM, a new gene down-regulated in metastasis.
Schwirzke, M., Gnirke, A., Bork, P., Tarin, D. and Weidle, U.H.
Anticancer Research 18 : 1409-1421. 1 May 1998

1997

Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
Fichtner, I., Dehmel, A., Naundorf, H. and Finke, L.H.
Anticancer Research 17 : 3633-3646. 1 January 1997

Expression of E-cadherin and catenins in invasive mammary carcinomas.
Zschiesche, W., Schoenborn, I., Behrens, J., Herrenknecht, K., Hartveit, F., Lilleng, P. and Birchmeier, W.
Anticancer Research 17 : 561-567. 1 January 1997

1996

Involvement of macrophages and cytokines into rejection mechanism of the drug-resistant and immunogenic murine lymphoma P388/adria.
Kisseleva, E., Becker, M., Lemm, M. and Fichtner, I.
Anticancer Research 16 : 1971-1978. 1 January 1996

1995

Effect of ALP analogs on inositol trisphosphate formation in H184 mammary epithelial cells before and after transfection with v-erb B oncogene.
Junghahn, I., Bergmann, J., Langen, P., Thun, I., Vollgraf, C. and Brachwitz, H.
Anticancer Research 15 : 449-454. 1 January 1995

1994

Multiple effects of antitumor alkyl-lysophospholipid analogs on the cytosolic free Ca2+concentration in a normal and a breast cancer cell line.
Bergmann, J., Junghahn, I., Brachwitz, H. and Langen, P.
Anticancer Research 14 : 1549-1556. 1 January 1994

Characterization of four drug resistant P388 sublines: resistance/sensitivity in vivo, resistance- and proliferation-markers, immunogenicity.
Fichtner, I., Stein, U., Hoffmann, J., Winterfeld, G., Pfeil, D. and Hentschel, M.
Anticancer Research 14 : 1995-2004. 1 January 1994

Multidrug resistance of murine leukemia cells characterization and correlation with cytochrome P-450 dependent activities, cytosolic calcium and cell cycle state.
Pfeil, D., Bergmann, J., Fichtner, I., Stein, U., Hentschel, M., Rothe, I. and Goan, S.R.
Anticancer Research 14 : 571-576. 1 January 1994

Cytotoxic effects of alkylphosphocholines or alkylphosphocholine-liposomes and macrophages on tumor cells.
Zeisig, R., Jungmann, S., Fichtner, I., Daemen, T. and Arndt, D.
Anticancer Research 14 : 1785-1790. 1 January 1994

1993

Retrovirus-mediated gene transfer of tumor necrosis factor alpha into colon carcinoma cells generates a growth inhibition.
Walther, W., Fichtner, I. and Uckert, W.
Anticancer Research 13 : 1565-1574. 1 January 1993

1992

Cytostatic effects of various alkyl phospholipid analoques on different cells in vitro.
Langen, P., Maurer, H.R., Brachwitz, H., Eckert, K., Veit, A. and Vollgraf, C.
Anticancer Research 12 : 2109-2112. 1 January 1992